Company: NEOV
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001683168-25-007304
Chunk: 226

Company: NeoVolta Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 1A
Chunk 226
---
 Conduct and Ethics applicable to all officers, directors and employees, which
is available on our website (www.neovolta.com) under “Governance” within the “Investors” section. We intend to
satisfy the disclosure requirement under Item 5.05 of Form 8-K regarding amendment to, or waiver from, a provision of this Code by posting
such information on the website address and location specified above.

ITEM 11. EXECUTIVE COMPENSATION

The
information required by this item is incorporated by reference to our proxy statement for the 2025 Annual Meeting of Stockholders to be
filed with the Securities and Exchange Commission within 120 days of the fiscal year ended June 30, 2025 and is incorporated into this
Annual Report on Form 10-K by reference.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL
OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The
information required by this item is incorporated by reference to our proxy statement for the 2025 Annual Meeting of Stockholders to be
filed with the Securities and Exchange Commission within 120 days of the fiscal year ended June 30, 2025 and is incorporated into this
Annual Report on Form 10-K by reference.

Securities Authorized for Issuance under Equity Compensation Plans

The following table sets forth
information regarding our equity compensation plans at June 30, 2025:

    Plan category

    Number of securities to be
    issued upon
    exercise of
    outstanding
    options,
    warrants and
    rights
    (a)

    Weighted-
    average exercise price
    of
    outstanding
    options,
    warrants and
    rights
    (b)

    Number of securities
    (by class) remaining
    available for future
    issuance under
    equity compensation
    plans (excluding
    securities reflected in
    column (a))
    (c)

    ﻿Equity compensation plans approved by security holders (1)

    7,500,000

    $
    3.30

    1,806,362

    (1)
    Represents shares of common stock issuable upon exercise of outstanding restricted stock units under our 2019 Stock Plan.

 43 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED
TRANSACTIONS, AND DIRECTOR INDEPENDENCE

The
information required by this item is incorporated by reference to our proxy statement for the 202